| Richard Lipton, MD | |
|
311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114-2781 | |
| (386) 255-1266 | |
| (386) 255-8520 |
| Full Name | Richard Lipton |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 311 N Clyde Morris Blvd, Daytona Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336153964 | NPI | - | NPPES |
| 062091200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME0056284 (Florida) | Primary |
| Entity Name | Sheridan Healthcorp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
A new £2.7 million international training network project, led by a team at Lancaster University, will develop a generation of medical statisticians dedicated to achieving early stage drug development success.
New ideas, systems and technologies are emerging to solve numerous health challenges facing the world's poorest communities. Some of the foremost experts on global health will discuss these and the prospects for health breakthroughs in the developing world at a media briefing at the Conrad N. Hilton Humanitarian Symposium at 2:30 pm on Monday, September 21.
A new material with antifungal and antitumor properties has been developed by researchers at the Center for Development of Functional Materials (CDMF), one of the Research, Innovation and Dissemination Centers (RIDCs) supported by São Paulo Research Foundation - FAPESP.
Many patients with incurable advanced colorectal cancer could be offered a more gentle treatment strategy starting with a single chemotherapy drug, as an alternative to current standard initial combination chemotherapy, without compromising their survival.
To reduce the likelihood of patient death and disability resulting from errors in the administration of injectable medications in hospitals and other healthcare settings, the U.S. Pharmacopeial Convention is advancing new labeling requirements that will standardize the information permitted on the highly visible area of these vials to only cautionary statements intended to prevent imminent life-threatening situations.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Lipton, MD 311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114-2781 Ph: (386) 255-1266 | Richard Lipton, MD 311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114-2781 Ph: (386) 255-1266 |
News Archive
A new £2.7 million international training network project, led by a team at Lancaster University, will develop a generation of medical statisticians dedicated to achieving early stage drug development success.
New ideas, systems and technologies are emerging to solve numerous health challenges facing the world's poorest communities. Some of the foremost experts on global health will discuss these and the prospects for health breakthroughs in the developing world at a media briefing at the Conrad N. Hilton Humanitarian Symposium at 2:30 pm on Monday, September 21.
A new material with antifungal and antitumor properties has been developed by researchers at the Center for Development of Functional Materials (CDMF), one of the Research, Innovation and Dissemination Centers (RIDCs) supported by São Paulo Research Foundation - FAPESP.
Many patients with incurable advanced colorectal cancer could be offered a more gentle treatment strategy starting with a single chemotherapy drug, as an alternative to current standard initial combination chemotherapy, without compromising their survival.
To reduce the likelihood of patient death and disability resulting from errors in the administration of injectable medications in hospitals and other healthcare settings, the U.S. Pharmacopeial Convention is advancing new labeling requirements that will standardize the information permitted on the highly visible area of these vials to only cautionary statements intended to prevent imminent life-threatening situations.
› Verified 3 days ago
Ebel Silva, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114 Phone: 386-255-1266 Fax: 386-255-8520 | |
Diane F Lapham, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1980 Lpga Blvd, Suite 210, Daytona Beach, FL 32117 Phone: 386-274-1744 Fax: 386-274-1644 | |
Sharif Al-ruzzeh, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 301 Memorial Medical Pkwy, Daytona Beach, FL 32117 Phone: 386-231-6000 | |
Dr. Linda W. Young, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-4000 | |
David Schultz, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114 Phone: 386-255-1266 Fax: 386-255-8520 | |
Daniela Holloway, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114 Phone: 386-255-1266 Fax: 385-255-8520 | |
Dr. Allen Edward Coleman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 352-733-0485 |